Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells

被引:30
作者
Suzuki, Yuko [1 ]
Mogami, Hideo [1 ]
Ihara, Hayato [1 ]
Urano, Tetsumei [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka, Japan
基金
日本学术振兴会;
关键词
VON-WILLEBRAND-FACTOR; EUGLOBULIN CLOT LYSIS; WEIBEL-PALADE BODIES; PROTEIN-KINASE-C; T-PA; MYOCARDIAL-INFARCTION; PLASMA-LEVELS; ACUTE RELEASE; EXOCYTOSIS; FIBRINOLYSIS;
D O I
10.1182/blood-2008-03-144279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the secretory dynamics of tissue plasminogen activator (tPA) in EA. hy926 cells, an established vascular endothelial cell (VEC) line producing GFP-tagged tPA, using total internal reflection-fluorescence (TIR-F) microscopy. tPAGFP was detected in small granules in EA. hy926 cells, the distribution of which was indistinguishable from intrinsically expressed tPA. Its secretory dynamics were unique, with prolonged (> 5 minutes) retention of the tPA-GFP on the cell surface, appearing as fluorescent spots in two-thirds of the exocytosis events. The rapid disappearance (mostly by 250 ms) of a domain-deletion mutant of tPA-GFP possessing only the signal peptide and catalytic domain indicates that the amino-terminal heavy chain of tPAGFP is essential for binding to the membrane surface. The addition of PAI-1 dose-dependently facilitated the dissociation of membrane-retained tPA and increased the amounts of tPA-PAI-1 high-molecularweight complexes in the medium. Accordingly, suppression of PAI-1 synthesis in EA. hy926 cells by siRNA prolonged the dissociation of tPA-GFP, whereas a catalytically inactive mutant of tPA-GFP not forming complexes with PAI-1 remained on the membrane even after PAI-1 treatment. Our results provide new insights into the relationship between exocytosed, membrane-retained tPA and PAI-1, which would modulate cell surface-associated fibrinolytic potential. (Blood. 2009; 113: 470-478)
引用
收藏
页码:470 / 478
页数:9
相关论文
共 45 条
[1]  
COLLEN D, 1991, BLOOD, V78, P3114
[2]   Real-time imaging of the dynamics and secretory behavior of Weibel-Palade bodies [J].
de Wit, TR ;
Rondaij, MG ;
Hordijk, PL ;
Voorberg, J ;
van Mourik, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) :755-761
[3]  
DEVRIES C, 1989, J BIOL CHEM, V264, P12604
[4]   PERMANENT CELL-LINE EXPRESSING HUMAN FACTOR-VIII-RELATED ANTIGEN ESTABLISHED BY HYBRIDIZATION [J].
EDGELL, CJ ;
MCDONALD, CC ;
GRAHAM, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3734-3737
[5]  
EMEIS JJ, 1988, BLOOD, V71, P1669
[6]   An endothelial storage granule for tissue-type plasminogen activator [J].
Emeis, JJ ;
vandenEijndenSchrauwen, Y ;
vandenHoogen, CM ;
dePriester, W ;
Westmuckett, A ;
Lupu, F .
JOURNAL OF CELL BIOLOGY, 1997, 139 (01) :245-256
[7]   Protease-activated receptor-1 activation of endothelial cells induces protein kinase Ca-dependent phosphorylation of syntaxin 4 and Munc18c [J].
Fu, J ;
Naren, AP ;
Gao, XP ;
Ahmmed, GU ;
Malik, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3178-3184
[8]   Annexin II: A mediator of the plasmin/plasminogen activator system [J].
Hajjar, KA ;
Krishnan, S .
TRENDS IN CARDIOVASCULAR MEDICINE, 1999, 9 (05) :128-138
[9]   Differential kinetics of cell surface loss of von Willebrand factor and its propolypeptide after secretion from Weibel-Palade bodies in living human endothelial cells [J].
Hannah, MJ ;
Skehel, P ;
Erent, M ;
Knipe, L ;
Ogden, D ;
Carter, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (24) :22827-22830
[10]   Successful silencing of plasminogen activator inhibitor-I in human vascular enclothelial cells using small interfering RNA [J].
Hecke, Anneke ;
Brooks, Hilary ;
Meryet-Figuiere, Matthieu ;
Minne, Stephanie ;
Konstantinides, Stavros ;
Hasenfuss, Gerd ;
Lebleu, Bernard ;
Schaefer, Katrin .
THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) :857-864